comparemela.com

Latest Breaking News On - Clinical meetings - Page 3 : comparemela.com

Ardelyx Reports First Quarter 2023 Financial Results and Provides Business Update

Ardelyx Reports First Quarter 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCaitlin lowieKimia keshtbodMike raabFosun pharmaExchange commission onExchange commissionDrug administrationArdelyx incCompany annual report on formMetis therapeutics incNational kidney foundationDrug applicationNew drug applicationClinical meetingsSerious dehydration

Zetomipzomib Reduces Proteinuria in Proliferative Lupus Nephritis

A post hoc analysis shows that zetomipzomib is effective in reducing proteinuria across all proliferative lupus nephritis classes.

United statesSamirv parikhNational kidney foundationOhio state university wexner medical centerClinical meetings

Conservative Kidney Management Often a Better Option for Older Adults With ESKD

Clinicians often fail to consider that dialysis is not necessarily the best option for many patients aged 75 years or older.

Johns hopkins universityUnited statesChristine corbettSusanpy wongBernardg jaarUniversity of washingtonNational kidney foundationsJohns hopkins university school of medicineClinical meetingsKidney failureOlder adultAll you wantedWere afraidJohns hopkins university schoolAssociate chief nursing officerPalliative care

Kidney Function Stable During 12 Months of Pegloticase-Methotrexate for Gout

Gout is a risk factor for CKD progression, so investigators probed the effect of pegloticase-methotrexate treatment on kidney function.

United statesBaylor college of medicineAbdul abdellatifNational kidney foundationClinical meetingsIncrease response ratesUncontrolled gout receiving krystexxaRenal diseaseBaylor collegeHorizon therapeutics

Kidney Function Stable During 12 Months of Pegloticase-Methotrexate for Gout

Gout is a risk factor for CKD progression, so investigators probed the effect of pegloticase-methotrexate treatment on kidney function.

United statesBaylor college of medicineAbdul abdellatifNational kidney foundationClinical meetingsIncrease response ratesUncontrolled gout receiving krystexxaRenal diseaseBaylor college

vimarsana © 2020. All Rights Reserved.